Tabuk Pharmaceuticals
Saudi Arabia - RiyadhPharmaceutical
Focus: Tabuk Pharmaceuticals is a mid-sized Saudi Arabian pharmaceutical manufacturer founded in 1994, focused on small-molecule development with operations spanning 1,001–5,000 employees. The company concentrates on neurology and non-pharmacological therapeutic interventions.
Profile data last refreshed 19h ago · AI intelligence enriched 3w ago
Funding Stage
PRIVATE
Employees
1001-5000
Open Jobs
0
About Tabuk Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Tabuk Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Diabetic care Information, education, and communication intervention will be delivered by relevant and trained health animators working in chronic care clinic.
Self-careClinical Trials (1)
NCT04847856Diabetic Self-care Education at Primary Health Care in Saudi Arabia: A Pragmatic Randomized Trial in Tabuk
N/AHelp build intelligence for Tabuk Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.